Relationship between non-specific prescription pill adherence and ischemic stroke outcomes - Wikidata - awgldk - TriplyDB

Relationship between non-specific prescription pill adherence and ischemic stroke outcomes

Relationship between non-specific prescription pill adherence and ischemic stroke outcomes

http://www.wikidata.org/entity/Q33620350

about

A new model for secondary prevention of stroke: transition coaching for stroke Impact of a better persistence with antihypertensive agents on ischemic stroke outcomes for secondary prevention.All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts.Pharmacist intervention for blood pressure control: medication intensification and adherence.Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes.Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.Medication adherence and stroke/TIA risk in treated hypertensives: results from the REGARDS study Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

P2860

Q34406631-3ED06E45-16AF-4564-BE6B-58928006DEFC Q34775628-B09B4C73-468F-4F58-A8B6-5614F4857672 Q35368427-48776A71-75EA-4FBE-BF8E-BD55665C95CE Q35868070-E72668FC-4F25-4D9A-9BD8-8B2F20EFA820 Q35883483-D468F0F7-8904-496F-93C8-44AC3ECD5128 Q36439201-107DB2EA-65BF-4ADE-B5E5-9BFE68C048ED Q36751595-4A485132-0BC2-4915-9D07-401BD9BD0163 Q37254060-A98595AA-7F55-4B45-8A88-0A3451ECFAC7 Q38561391-075B9A1B-D453-4EC9-B474-F52288C2D7DF Q47346236-07C2176E-A461-42CB-BC51-21694D68A76C

P2860

Relationship between non-specific prescription pill adherence and ischemic stroke outcomes

http://www.wikidata.org/entity/Q33620350

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Relationship between non-speci ...... e and ischemic stroke outcomes

@ast

Relationship between non-speci ...... e and ischemic stroke outcomes

@en

type

label

Relationship between non-speci ...... e and ischemic stroke outcomes

@ast

Relationship between non-speci ...... e and ischemic stroke outcomes

@en

prefLabel

Relationship between non-speci ...... e and ischemic stroke outcomes

@ast

Relationship between non-speci ...... e and ischemic stroke outcomes

@en

P1433

Q33620350-6955CD64-9EE8-4E5A-840E-4D2D3D500FBF

P1476

Q33620350-00E42AEE-80CF-499B-B8DB-5A332B901030

P2093

Q33620350-8B87EC95-D4D5-4A35-89B4-73E33047AA82

Q33620350-D6C4243E-6867-4FD2-8045-475DF786819A

Q33620350-DC585B21-48EF-48B5-9808-6722D26C0A84

Q33620350-FA192D41-4EA6-4C9D-81F4-BDEBFFCBB262

P2860

Q33620350-029A58E6-22C2-4BE0-BF83-490684B791F6

Q33620350-5F225761-FCEC-4751-927F-2D1622F99071

Q33620350-664DF3C3-7A49-456F-BA31-5314D3132461

Q33620350-71CC298F-C904-4C2C-B2C5-6C61609A24A2

Q33620350-7207D8C8-9157-4F63-BF07-4544E2E05F37

Q33620350-7B86F946-2847-496C-9AA9-6F2451BFF351

Q33620350-A2822ADF-D23B-4C4D-839B-075EBC51B175

Q33620350-C333A371-7CED-40C7-89B8-32B3CE32B743

Q33620350-C6BB8EAE-D9EC-428B-BB4F-0D91D96DDD6B

Q33620350-CEB923F5-771B-40C4-9BB3-0976320168AF

P304

Q33620350-3A57B9CE-EEFD-46FD-888D-FB746006077F

P31

Q33620350-E4B68862-3E41-44CE-A392-32E3A7318EF0

P356

Q33620350-0B3AD6E1-D30E-4A8A-8C80-832CBFC44F20

P433

Q33620350-015B0DB3-97F5-4013-88EB-02318C89381E

P478

Q33620350-9BD9D6BA-0440-474A-AA2D-012648231DD1

P50

Q33620350-B4FF1EE3-1DAE-473D-B92B-B9F616AFB79A

P577

Q33620350-785F500D-483F-4F90-8418-BA4A80814A87

P5875

Q33620350-6E3F1B2F-388E-415B-921D-01FF6E210828

P698

Q33620350-697505BF-1640-4CA9-B4F2-3E12A4626C92

P932

Q33620350-47069501-8FA8-4A11-B25F-AAB7ABD0A06C

P356

P1433

Cerebrovascular Diseases

P1476

Relationship between non-speci ...... e and ischemic stroke outcomes

@en

P2093

Ali Faiz

http://www.w3.org/2001/XMLSchema#string

Lloyd E Chambless

http://www.w3.org/2001/XMLSchema#string

Stephen Campbell

http://www.w3.org/2001/XMLSchema#string

VISP Study Investigators

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of the association between adherence to drug therapy and mortality

Stroke prevention: narrowing the evidence-practice gap.

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Ensuring management of vascular risk factors after stroke.

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.

Treatment adherence and risk of death after a myocardial infarction.

Virological failure and adherence to antiretroviral therapy in HIV-infected patients.

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

P304

146-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000262311

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Bruce Ovbiagele

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40442881

http://www.w3.org/2001/XMLSchema#string

P698

19955739

http://www.w3.org/2001/XMLSchema#string

P932

2813814

http://www.w3.org/2001/XMLSchema#string